Public biotechs raising funds? In this economy? A trio of companies brings $1.5B+ to battered sector after PhIII wins
Over the last 24 hours, something strange has happened in biotech: Public companies are raising money — and quite a lot, at that.
Following Nasdaq’s closing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
